LP17 : Novel approach for the prevention of recurrent hepatitis C in liver transplant recipients: Preliminary results from ongoing phase III trial with civacir®
Autor: | Terrault, N., Shrestha, R., Satapathy, S.K., O’Leary, J.G., Campsen, J., Rosenau, J., Spivey, J., Teperman, L.W., Therapondos, G., Verna, E.C., Vierling, J.M., Schiano, T.D., Sher, L., Khallafi, H., Victor, D., Bhamidimarri, K.R., Gordon, F.D., Hanish, S., Kulik, L.M., Lake-Bakaar, G., Maluf, D., Porayko, M., Bramer, S.L, Osgood, G., Chavan, S., Daelken, N. |
---|---|
Zdroj: | In Journal of Hepatology April 2015 62 Supplement 2:S271-S272 |
Databáze: | ScienceDirect |
Externí odkaz: |